Depression is caused by identifiable changes in brain networks. We can restore healthy neural activity and relieve symptoms of depression.
Depression is caused by identifiable changes in brain networks. We can restore healthy neural activity and relieve symptoms of depression.
Magnus Medical Launches with $25M in Series A Financing
We are developing breakthrough technology for rapid, individualized, non-invasive treatment of major depression. A randomized controlled trial just published in the American Journal of Psychiatry showed relief of severe depression in 79% of people receiving active treatment. Read the Press Release.
FDA awards Breakthrough Device Designation
The FDA has awarded Breakthrough Device Designation to Magnus Medical’s non-invasive technology to rapidly treat major depressive disorder (MDD) in adults who have not responded to existing treatments.
Patrick J. Kennedy writes about a watershed moment brought about by neuroscientists to gain ground against diseases of the brain. Read the article.
Breakthrough algorithms can identify optimal, personalized targets to affect brain circuitry based on structural and functional neuroimaging.
Precise patterns of stimulation, leveraging recent advances in neuroscience, can restore these circuits and yield profound effects.
Magnus Medical is creating the next generation of neuromodulation technology to improve the quality of life for people suffering from mental illness… rapidly, effectively, and durably.
Our team is growing. We are looking for individuals who are personally and boldly committed to improving treatment for mental health. Please view our open positions HERE.